Distinct Thromboxane A₂–Dependent Pathways Regulate Arachidonic Acid–Triggered VASP Phosphorylation at Ser239 and Ser157 in Human Platelets: Real‐Time Visualization Reveals Superior Antithrombotic Efficacy by Targeting Thromboxane A₂ Signaling over Cyclooxygenase Inhibition
Journal of Cellular Physiology · 2026-03 · 241 (3)
DOI: 10.1002/jcp.70160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, online erschienen am 09.03.2026. Verfasst von Joen-Rong Sheu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Phosphoproteins, Cell Adhesion Molecules, Blood Platelets, Microfilament Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, Taipei Medical University, Cathay General Hospital.
Abstract (Originalsprache)
Platelets, as anucleate blood cells, play a pivotal role in the pathogenesis of cardiovascular diseases (CVDs), making antiplatelet therapy essential for preventing thrombotic events such as myocardial infarction. Thromboxane A₂ (TXA₂) is a key pro‐aggregatory mediator that drives platelet activation. Phosphorylation of vasodilator‐stimulated phosphoprotein (VASP) at Ser157 and Ser239 serves as a marker of cyclic nucleotide‐mediated inhibitory signaling. The crosstalk between TXA₂ signaling and site‐specific VASP phosphorylation in arachidonic acid (AA)‐stimulated human platelets remains unclear and requires further investigation. In this study, AA at 60 µM induced maximal platelet activation, as evidenced by ultrastructural changes and increased P‐selectin expression. Picotamide, a thromboxane synthase (TXS) inhibitor, effectively reversed AA‐induced alterations, including ultrastructural remodeling, P‐selectin expression, TXA₂ production, adenosine triphosphate (ATP)‐release, mobilization of [Ca²⁺]ᵢ, and integrin α IIb β 3 activation. Importantly, picotamide's inhibition of platelet aggregation was unaffected by adenylate or guanylate cyclase inhibitors, suggesting a mechanism independent of cyclic nucleotide signaling. AA selectively increased VASP phosphorylation at Ser239, but not Ser157. While picotamide alone had no effect, its sequential administration with AA significantly enhanced Ser157 phosphorylation without altering Ser239 levels. These findings suggest that AA differentially regulates VASP phosphorylation sites via distinct mechanisms: Ser239 via a TXA₂‐independent pathway associated with inhibitory signaling, and Ser157 via a TXA₂‐dependent pathway linked to platelet activation. Finally, picotamide demonstrated superior antithrombotic efficacy compared to aspirin at an equivalent dose, as evidenced by real‐time intravital imaging of thrombotic platelet plug formation in vivo. These results highlight TXS inhibition as a promising strategy for modulating platelet activation and thrombosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
- Department of Cardiovascular Center, Cathay General Hospital, Taipei, Taiwan.
- School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
- Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan.
- Translational Medicine Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Förderung
- National Science and Technology Council
- Taipei Medical University
- Cathay General Hospital
Zitieren
APA
Sheu, J. R., Huang, W. C., Chang, C. C., Hsia, C. W., Hsia, C. H., Jayakumar, T., & Hou, S. M. (2026). Distinct Thromboxane A₂–Dependent Pathways Regulate Arachidonic Acid–Triggered VASP Phosphorylation at Ser239 and Ser157 in Human Platelets: Real‐Time Visualization Reveals Superior Antithrombotic Efficacy by Targeting Thromboxane A₂ Signaling over Cyclooxygenase Inhibition. Journal of Cellular Physiology, 241(3). https://doi.org/10.1002/jcp.70160
Vancouver
Sheu JR, Huang WC, Chang CC, Hsia CW, Hsia CH, Jayakumar T, et al. Distinct Thromboxane A₂–Dependent Pathways Regulate Arachidonic Acid–Triggered VASP Phosphorylation at Ser239 and Ser157 in Human Platelets: Real‐Time Visualization Reveals Superior Antithrombotic Efficacy by Targeting Thromboxane A₂ Signaling over Cyclooxygenase Inhibition. Journal of Cellular Physiology. 2026;241(3). doi:10.1002/jcp.70160
BibTeX
@article{Sheu2026,
author = {Sheu, Joen-Rong and Huang, Wei-Chieh and Chang, Chao-Chien and Hsia, Chih-Wei and Hsia, Chih-Hsuan and Jayakumar, Thanasekaran and Hou, Shaw-Min},
title = {Distinct Thromboxane A₂–Dependent Pathways Regulate Arachidonic Acid–Triggered VASP Phosphorylation at Ser239 and Ser157 in Human Platelets: Real‐Time Visualization Reveals Superior Antithrombotic Efficacy by Targeting Thromboxane A₂ Signaling over Cyclooxygenase Inhibition},
journal = {Journal of Cellular Physiology},
year = {2026},
volume = {241},
number = {3},
doi = {10.1002/jcp.70160}
}
EUVIMED